The Pharmaceutical Market: South Africa Opportunities and Challenges

Publisher Name :
Date:8-Nov-2012
No. of pages: 103

OVERVIEW OF THE PHARMACEUTICAL MARKET IN SOUTH AFRICA

The government drive to support local production and reduce the country’s reliance on imports, in addition to global epidemiological and demographic trends, are all positive factors contributing to long-term growth in the pharmaceutical market. However, deep segregation between private and public healthcare facilities continues to leave the vast majority of the population without medical care. BMI believes this will be rectified through the creation of the National Health Insurance scheme over the next decade, but in the meantime unemployment, lack of education and geographical inaccessibility to healthcare for the wider population will continue to hinder growth in the market.

Headline Expenditure Projections Pharmaceuticals: ZAR27.19bn (US$3.74bn) in 2011 to ZAR29.61bn (US$3.61bn) in 2012; +8.9% in local currency and -3.5% in US dollar terms. Healthcare: ZAR261.51bn (US$36.01bn) in 2011 to ZAR285.26bn (US$34.79bn) in 2012; +9.1% in local currency terms and -3.4% in US dollar terms. Medical devices: ZAR11.43bn (US$1.57bn) in 2011 to ZAR12.19bn (US$1.49bn) in 2012; +6.7% in local currency terms and -5.5% in US dollar terms. Forecast changed due to depreciation of the South African rand.

Product Description

The South Africa Pharmaceuticals & Healthcare Report features Espicom’s forecasts for drugs and healthcare expenditure and imports and exports, focusing on the growth outlook for the prescription, OTC, patented drugs and generics market segments.

Espicom’s South Africa Pharmaceuticals & Healthcare Report provides industry professionals, strategists, company executives, investors, analysts and sales/marketing heads with independent forecasts and competitive intelligence on the South Africa pharmaceutical and healthcare industry.

Key Benefits

  • Benchmark Espicom’s independent pharmaceutical and healthcare industry forecasts to test other views – a key input for successful budgeting and strategic business planning in the South Africa pharmaceutical and healthcare market.
  • Target business opportunities and risks in the pharmaceutical and healthcare sector through our reviews of latest industry trends, regulatory changes and major deals, projects and investments in South Africa.
  • Assess the activities, strategy and market position of your competitors, partners and clients via our Company Profiles (inc. SWOTs, KPIs and latest activity) and Competitive Landscape Tables.

Executive Summary & Industry SWOT

An at-a-glance perspective on latest regulatory developments, key forecast indicators and major corporate developments, covering the prescription, OTC and generics markets. The SWOT outlines strategic factors which affect Espicom’s forecast analysis, and taken together with Espicom’s political, economic and business environment SWOTS, it gives a complete overview of market climate.

Market Summary
Snapshot of key market characteristics, including total size of pharmaceuticals and healthcare segments, growth drivers, leading therapeutic areas and the competitive landscape.

Regulatory Regime
Details of the industry regulatory framework and key legislation covering the licensing of new products/services, pricing and reimbursements, intellectual property, taxation and advertising, as well as an analysis of the overall regulatory burden.

Industry Developments
Focus on government healthcare reforms, epidemiological trends, company M&As, product launches, market entries, FDI activity, R&D, biotechnology, clinical trials and supply chain issues.

Espicom Industry Forecasts
Forecasts to end-2016 for all key industry indicators (see list below) supported by explicit assumptions, plus analysis of key downside risks to the main forecast, including:

  • Healthcare: Total healthcare expenditure (US$bn), healthcare expenditure (% of GDP), healthcare expenditure per capita (US$), hospital beds (per `000 population), doctors (per `000 population), birth and mortality rate (per `000 population)
  • Pharmaceutical market: Drug expenditure (US$bn), drug expenditure (% of GDP), drug expenditure per capita (US$)
  • Patented drug market: Prescription drug sales (US$bn), prescription sales (% of total sales), sales broken down by 14 therapeutic areas (cardiovascular, anti-infectives etc.)
  • Generic drug market: Generic product sales (US$bn), generic sales (% of total sales)
  • OTC drug market: OTC sales (US$bn), OTC sales (% of total sales), sales broken down by product types (analgesics, skin treatments, vitamins and minerals etc.)
  • Medical Devices: Medical device sales (US$bn), medical device sales (% of total healthcare market)
  • Macroeconomic Forecasts: Nominal and real GDP, % real GDP growth, % private consumption growth, % industrial output growth, % consumer price index, % GDP price deflator, exports, imports, trade balance, current account balance, foreign direct investment, exchange rate against US$, government expenditure, external debt.

Competitive Landscape

The competitive landscape section provides comparative company analyses and rankings by US$ sales and % share of total sales – for the total pharmaceutical sector, as well as the OTC, generics, and distribution sub-sectors.

Company Profiles

Examines the competitive positioning and short- to medium-term business strategies of key industry players. Strategy is examined within the context of Espicom’s industry forecasts, our macroeconomic views and our understanding of the wider competitive landscape to generate Company SWOT analyses. The latest financial and operating statistics and key company developments are also incorporated within the company profiles, enabling a full evaluation of recent company performance and future growth prospects.

The Pharmaceutical Market: South Africa Opportunities and Challenges

EXECUTIVE SUMMARY... 1
Snapshot: Strategic Espicom Analysis.........2
Snapshot: Key Data Projections......3

MACROENVIRONMENT . 4

POLITICAL.....4

ECONOMIC...5
Projections...........5

LEGAL............6

DEMOGRAPHIC........7
Projections...........7
Latest Figures.......8
Demographic Indicators..9
Birth Rate... 9
Death Rate. 9
Infant MortalityRate (IMR) 9
Life Expectancy at Birth.... 9

EPIDEMIOLOGY............ 10

DISEASE BURDEN...10

DISEASE PREVALENCE........11
Communicable Diseases11
HIV/AIDS... 11
Malaria...... 11
TB.. 12
Non-Communicable Diseases....12
Cancer....... 12

HEALTHCARE - ACCOMPANYING HEALTH STATISTICS.. 13

ORGANISATION......13
National Health Insurance..........13

EXPENDITURE.........14
Projections.........14
Latest Figures.....15

INFRASTRUCTURE..16
Hospital Infrastructure..16
Netcare Group ..... 17
Hospital Bed Provision...17

WORKFORCE...........18
Projections.........18
Physicians...........19
Public Workforce............19

REGULATORY AFFAIRS 20

NATIONAL AUTHORITY..... 20

MARKETING REGISTRATION.......... 20
National Procedures.......20

TRADE REGULATIONS ........21
Parallel Trade.....21

PRICING & REIMBURSEMENT... 22

NATIONAL AUTHORITY..... 22

PRICING...... 22
Dispensing Fees Charged by Pharmacists..........22

REIMBURSEMENT . 23
Essential Drugs List........23

DISTRIBUTION CHANNELS....... 24

DRUG RETAILING....24
Public Pharmacies............24
Private Pharmacies..........24
Pharmacy Trade Association......25
USAP.........25
Leading Pharmacy Chains..........25
Clicks.........25
Dischem...25
Medipost Courier Pharmacy.......25

MARKET ANALYSIS....... 26

SIZE 26
Projections.........26
Historical Figures............28
Current Structure............29
ARV Tender...........30

PRODUCT DEVELOPMENT 30

MANUFACTURING. 30

TRADE.........31
Exports..31
Imports..33
Balance of Trade38

COMPETITION.. 39

TRADE ASSOCIATION..........39

PIASA........39

COMPANY INTELLIGENCE. 40
Adcock Ingram.....40
Aspen Pharmacare...........40
Merck South Africa........... 41
Competitive Strategies..41
OTC PHARMACEUTICALS.......... 43

MARKET SIZE...........43

COMPETITION.........43
Trade Association...........43
SMASA......43

GENERIC PHARMACEUTICALS 44

MARKET SIZE.......... 44

COMPETITION........ 44
Trade Association...........44
NAPM........44
Company Intelligence....45
Aspen Pharmacare...........45
Cipla Medpro........45
Ranbaxy...45

BIOLOGICS & BIOSIMILARS......46

PRODUCT DEVELOPMENT 46
Lifelab.......46
TIA46

COMPETITION........ 46
Trade Association...........46
IMSA..........46
Company Intelligence....47
Arvir Technologies........... 47
Bioclones.. 47
Elevation Biotech. 47
iThemba Pharmaceuticals........... 47
Key Oncologics..... 47
National Bioproducts Institute... 47

CONCLUSIONS: OPPORTUNITIES & CHALLENGES.........48
Strategic Espicom Analysis............ 48
MACROENVIRONMENT...48
EPIDEMIOLOGY..48
HEALTHCARE......48
REGULATORY AFFAIRS....49
PRICING & REIMBURSEMENT......49
DISTRIBUTION CHANNELS..........50
MARKET.50
COMPETITION ....51
OTC PHARMACEUTICALS51
GENERIC PHARMACEUTICALS.....51
BIOLOGICS & BIOSIMILARS.........51
Radar Analysis........53
SWOT Analysis........53

DIRECTORY...... 54

COMPETITION........ 54
Pharmaceutical Companies........54
Generic Companies........54
Biologic Companies........54

GOVERNMENT ORGANISATIONS.. 54

PRODUCT DEVELOPMENT 54

TRADE ORGANISATIONS... 54

List of Tables
Espicom Analysis of the Pharmaceutical Market, 2012.. 2
Key Data Projections, 2011-2016.......... 3
Political Landscape, 2012........ 4
Regional Ranking of Projected Economies, 2016........... 5
Projected Economy, 2011-2016............ 5
Regional Ranking of Projected Demographics, 2016..... 7
Projected Demographics, 2011-2016... 7
Population by Gender & Province, 2011............ 8
Population by Gender & Age, 2011...... 8
Births, Deaths & Natural Increase, 1997-2010.. 9
Selected Causes of Death by Sex, 2007-2009.. 10
Estimated Number of Adults & Children Receiving ART, 2005-2010.......11
Reported Cases of Selected Communicble Diseases, 1990-201012
Regional Ranking of Projected Health Expenditure, 2016........ 14
Projected Health Expenditure, 2011-2016....... 14
Health Funding by Sector, 2007/08-2009/10 (Rand Millions)...15
Public Sector Hospitals by Province, 2004-2011........... 16
Private Sector Hospitals by Province, 2004-2010......... 16
Public Sector Hospital Beds by Province, 2005-2009....17
Private Sector Hospital Beds by Province, 1998-2010...17
Regional Ranking of Projected Physicians, 2016.......... 18
Projected Physicians, 2011-2016........ 18
Physicians by Province, 2009-2011.... 19
Public Physicians, Nurses, Dentists & Pharmacists, 2000-2011 19
Regional Ranking of Projected Pharmaceutical Markets, 2016 26
Projected Pharmaceutical Market at Retail Prices, 2011-2016.. 28
Historical Pharmaceutical Market at Retail Prices, 1995-2010. 28
Pharmaceutical Retail Sales by Month at Current Prices, 2005-2011 (R Millions) 29
Pharmaceutical Exports by Category, 1995-2010 (US$000s).... 31
Pharmaceutical Exports by Country/Region, 2010 (US$000s).. 32
Pharmaceutical Imports by Category, 1995-2010 (US$000s)... 33
Imports of Raw Materials by Country/Region, 2010 (US$000s)............ 35
Imports of Antisera & Vaccines by Country/Region, 2010 (US$000s).... 36
Imports of Medicaments by Country/Region, 2010 (US$000s) 37
Balance of Pharmaceutical Trade, 1995-2010 (US$000s)......... 38
Member Companies of PIASA, 2011... 39
Member Companies of SMASA, 2011. 43
Member Companies of NAPM, 2011..44
Member Companies of IMSA, 2011....46
Espicom Analysis of the Pharmaceutical Market, 2012 52
SWOT Analysis of the Pharmaceutical Market, 2012... 53

List of Charts
Regional Comparison of Projected Pharmaceutical Markets at Retail Prices, 2016 27
Regional Comparison of Projected Pharmaceutical Market Share, 2016........... 27
Historical Pharmaceutical Market at Retail Prices, 1995-2010. 29
Pharmaceutical Exports, 1995-2010 (US$ Millions) .... 31
Pharmaceutical Imports, 1995-2010 (US$ Millions).... 33
Pharmaceutical Imports by Country/Region, 2010 (%)............ 34
Balance of Pharmaceutical Trade, 1995-2010 (US$ Millions)... 38
Radar Graph of the Pharmaceutical Market, 2012...... 53

  • Challenges in the Tourism Industry in Thailand
    Thailand has always been a popular tourist destination and tourism provides a major boost to the country’s economy. Bangkok, Hua Hin, Krabi, Samui, Phuket and Cha Am are some of the most attractive tourist destinations in the country. In 2012, Thailand had a very high number of arrivals. Even the number of Thai citizens who [...]
  • Future of the US Consumer Electronics Market
    The market for consumer electronics has been growing steadily. Some of the factors that are contributing to the growth in the market are technological advancement, rise in disposable income and increasing demand for new products. During 2012, consumer electronics market in the US demonstrated positive expansion, although the growth rate slowed down considerably following the [...]
  • Overview of the Global Retail Market
    The global retail industry continued to grow despite the difficult economic conditions in the world. In the fiscal year of 2011, sales-weighted, currency-adjusted revenue rose by 5.1% to $4.271 trillion for the world’s top 250 retailers. According to GRDI (Global Retail Development Index), in 2013 Brazil occupied the top spot in retail development. Chile and [...]
  • Bright Future Predicted for the Tourism Industry in Singapore
    Travel and tourism industry in Singapore has been growing at a steady rate and is considered to be a major contributor to the economic growth of the country. In 2012, Singapore’s IVA (International Visitors Arrivals) reached a record high of 14.5 million, with a growth rate of 10.1% year-on-year. In recent years, inbound travel to [...]
  • Potential of Staffing Market in United States
    The staffing industry places individuals into contract, temporary and permanent positions in firms around the world. Major staffing markets include France, Spain, Italy and Japan as well as many emerging markets. Temporary staffing around the world has been growing, but in US temporary market has been flat since 2006. The majority of staffing revenue majorly [...]
  • 2014 Deep Research Report on Global and China Glucosamine Industry
    Published: 8-Jul-2014        Price: US $2200 Onwards        Pages: 179
    This is a professional and depth research report on Global and China Glucosamine industry. The report firstly introduced Glucosamine basic information included Glucosamine definition classification application industry chain structure industry overview; international market analysis, China domestic market analysis, Macroeconomic environment and economic situation analysis, Glucosamine industry policy and plan, Glucosamine product specification, manufacturing process, cost structure etc. then sta......
  • 2014 Deep Research Report on Global and China Coenzyme Q10 Industry
    Published: 8-Jul-2014        Price: US $2200 Onwards        Pages: 170
    This is a professional and depth research report on Global and China Coenzyme Q10 industry. The report firstly introduced Coenzyme Q10 basic information included Coenzyme Q10 definition classification application industry chain structure industry overview; Coenzyme Q10 production and sales by manufacturers by technology by regions or countries, and also introduced global key manufacturers manufacturing bases and capacity distribution, Coenzyme Q10 product specification, manufacturing process, pr......
  • Emerging Pharmaceuticals Markets in China
    Published: 1-Jul-2014        Price: US $4000 Onwards        Pages: 212
    China's demand for Emerging Pharmaceuticals has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2003, 2008 and 2013) and long-term forecasts through 2018 and 2023 are presented. Major producers in China are prof......
  • Global Vitamin and Provitamin Market to 2018 – Market Size, Growth, and Forecasts in Nearly 70 Countries
    Published: 1-Jul-2014        Price: US $2710 Onwards        
    This is a comprehensive publication that enables readers the critical perspectives to be able to evaluate the world market for vitamins and provitamins. The publication provides the market size, growth and forecasts at the global level as well as for the following countries:Argentina, Armenia, Australia, Austria, Azerbaijan, Belgium, Bolivia, Bulgaria, Canada, Chile, China, Colombia, Czech Republic, Denmark, Ecuador, Egypt, Estonia, Ethiopia, Finland, France, Georgia, Germany, Ghana, Greece,......
  • EpiCast Report: Graft-Versus-Host Disease – Epidemiology Forecast to 2023
    Published: 1-Jul-2014        Price: US $3995 Onwards        Pages: 56
    Graft-versus-host disease (GVHD) is a common complication of allogeneic hematopoietic stem cell transplantation (HSCT) that occurs when the donated (graft) cells are rejected and attack the host's cells as foreign. GVHD can progress from mild to severe forms as either acute GVHD (aGVHD) or chronic GVHD (cGVHD). Both aGVHD and cGVHD commonly affect organs such as the skin, gastrointestinal (GI) tract, liver, oral mucosa, and eyes.GlobalData epidemiologists forecast an increase in the diagnose......
  • Burkholderia Infections – Pipeline Review, H1 2014
    Published: 30-Jun-2014        Price: US $2000 Onwards        Pages: 32
    Global Markets Direct's, ‘Burkholderia Infections Pipeline Review, H1 2014', provides an overview of the Burkholderia Infections's therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Burkholderia Infections, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. I......
  • Wet (Neovascular / Exudative) Macular Degeneration – Pipeline Review, H1 2014
    Published: 30-Jun-2014        Price: US $2000 Onwards        Pages: 202
    Global Markets Direct's, ‘Wet (Neovascular / Exudative) Macular Degeneration Pipeline Review, H1 2014', provides an overview of the Wet (Neovascular / Exudative) Macular Degeneration's therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Wet (Neovascular / Exudative) Macular Degeneration, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and ......
  • GenSight Biologics – Product Pipeline Review – 2014
    Published: 30-Jun-2014        Price: US $1500 Onwards        Pages: 23
    Global Markets Direct's, ‘GenSight Biologics Product Pipeline Review 2014', provides an overview of the GenSight Biologics's pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of GenSight Biologics's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, ......
  • Insulin Resistance – Pipeline Review, H1 2014
    Published: 30-Jun-2014        Price: US $2000 Onwards        Pages: 67
    Global Markets Direct's, ‘Insulin Resistance Pipeline Review, H1 2014', provides an overview of the Insulin Resistance's therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Insulin Resistance, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs